Companies: 10,795·Total market cap: $144.5T
Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc.

STOKNASDAQHealthcare● Active
$29.36
$-0.65(-2.15%)
Market Cap$1.8B
P/E Ratio
52W High$40.22
52W Low$10.635
Overview

Stoke Therapeutics, Inc. (STOK) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · STOK · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-2.83stok eps ttm · stok earnings per shareEarnings history
PE Ratio (TTM)stok pe ratio ttm · stok price to earningsPE Ratio deep dive
Revenue (TTM)$32.1Mstok revenue ttm · stok annual revenueFull revenue history
Dividend YieldNo Dividenddoes stok pay dividends · stok dividend yieldDividend history
Shares Outstanding59.2Mstok shares outstanding · stok floatShares outstanding history
Next EarningsAug 11, 2026Est.stok earnings date · stok next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$184.4M▲ +404.50% YoY
202320242025
stoke therapeutics, inc. revenue · stok revenue 2025
FY 2025Net Income-$6.9M▲ +92.26% YoY
202320242025
stoke therapeutics, inc. net income · stok profit 2025
FY 2025EPS$-0.12▲ +92.73% YoY
202320242025
stok eps · stoke therapeutics, inc. earnings per share 2025
TTM:Revenue: $32.1MNet Income: -$169.8MEPS: $-2.83View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy15 analystsis stok a buy · stok analyst rating
Strong Buy
0
Buy
12
Hold
3
Sell
0
Strong Sell
0
12-Month Price Target
$35.00Low
$29.36Current
$43.86Avg Target49.37% upside
$60.00High
stok price target · stok 12 month forecast

Total: 15 · Buy rate: 80.0%

The STOK analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $43.86, representing +49.37% upside from the current price of $29.36.

Stock Performance

Full History
1D-3.00%
1W-0.51%
1M-11.49%
3M-17.95%
YTD-8.29%
1Y+161.55%
5Y-27.89%

About Stoke Therapeutics, Inc.

CEOIan F. Smith
IPO DateJun 19, 2019
Employees128
CountryUS

Stoke Therapeutics, Inc. an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United Sta…

what is stoke therapeutics, inc. · stok stock overview · stoke therapeutics, inc. company profile · who is stoke therapeutics, inc. ceo · stok NASDAQ · stoke therapeutics, inc. headquarters · stoke therapeutics, inc. business segments

About Stock Overview & Key Data

Stoke Therapeutics, Inc. (STOK) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 19, 2019. As of the latest trading session, STOK stock price is $29.36, with a market capitalization of $1.8B. The stock has returned +161.55% over the past 12 months and -8.29% year-to-date.

According to 15 Wall Street analysts, the consensus rating for Stoke Therapeutics, Inc. stock is Buy, with an average 12-month price target of $43.86. In fiscal year 2025, Stoke Therapeutics, Inc. reported revenue of $184.4M and net income of -$6.9M. For detailed data — including Stoke Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Stoke Therapeutics, Inc. (STOK) stock price is $29.36. The stock is traded on NASDAQ under the ticker symbol STOK. The 52-week range is $10.63 – $40.22.

STOK stock priceSTOK quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice